Thromboprophylaxis in people hospitalized with COVID‐19: Assessing intermediate or standard doses in a retrospective cohort study

BACKGROUND AND OBJECTIVES: Current clinical guidelines recommend thromboprophylaxis for adults hospitalized with coronavirus disease 2019 (COVID‐19), yet it is unknown whether higher doses of thromboprophylaxis offer benefits beyond standard doses. METHODS: We studied electronic health records from...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Kathleen M., Joseph, Corey S., Mehta, Hemalkumar B., Streiff, Michael B., Betz, Joshua F., Bollinger, Robert C., Fisher, Arielle M., Gupta, Amita, LeMaistre, Charles F., Robinson, Matthew L., Xu, Yanxun, Ng, Derek K., Alexander, G. Caleb, Garibaldi, Brian T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287673/
https://www.ncbi.nlm.nih.gov/pubmed/35859579
http://dx.doi.org/10.1002/rth2.12753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287673/
https://www.ncbi.nlm.nih.gov/pubmed/35859579
http://dx.doi.org/10.1002/rth2.12753

Ejemplares similares